Search

Currently, detectors have made significant progress in inference speed and accuracy. However, these detectors require Non-Maximum Suppression (NMS) during the post-processing stage to eliminate redundant boxes, which limits the optimization of model inference speed. We first analyzed the reason for the dependence on NMS in the post-processing stage. The result showed that a score loss in a one-to-many label assignment leads to the presence of high-quality redundant boxes, making them difficult to remove. To realize end-to-end object detection and simplify the detection pipeline, we propose herein a mixed label assignment (MLA) training method, which uses one-to-many label assignment to provide rich supervision signals, alleviating the performance degradation, and we eliminate the need for NMS in the post-processing stage by using one-to-one label assignment. Additionally, a window feature propagation block (WFPB) is introduced, utilizing the inductive bias of images to enable feature sharing in local regions. Through these methods, we conducted experiments on the VOC and DUO datasets; our end-to-end detector MA-YOLOX achieved 66.0 mAP and 52.6 mAP, respectively, outperforming the YOLOX by 1.7 and 1.6. Additionally, our model performed faster than other real-time detectors without NMS. [ABSTRACT FROM AUTHOR]

Purpose: To evaluate the safety and efficacy of Innospring® stent, a novel self-expanding interwoven nitinol stent, in treating femoropopliteal atherosclerotic lesions. Methods: A prospective, single-center, single-arm, first-in-human study enrolled 15 patients (mean age 73.1 years; 13 men) to evaluate the safety and efficacy of the Innospring® stent monitored by core laboratories. The inclusion criteria were claudication or ischemic rest pain, de novo lesions or nonstented restenosis, >70% stenosis, lesion length <20 cm, and a reference vessel diameter of 4–7 mm. The primary safety endpoint was 30-day major adverse events. The primary efficacy end point was stent patency at 12 months. Follow-up evaluations were conducted at 30 days, 6 months, and 12 months. Results: The lesion length was 6.1 ± 3.5 mm. Fourteen (93.3%) patients had lesions of the superficial femoral artery and 3 (20.0%) patients had lesions of the popliteal artery. Nine (60.0%) patients had moderate-to-severe calcified lesion. Technical and procedural success was 100%. No patients experienced major adverse events in the first 30 days. The Rutherford category showed significant and sustained improvement at 6 and 12 months. The 12-month follow-up radiographs obtained in 13 patients confirmed the absence of stent fractures in 100% of examinations. The cumulative primary stent patency rate at 6 and 12 months were 93.3% and 84.6%, respectively. Conclusion: Stenting of the superficial femoral and popliteal arteries using the Innospring® stent is safe and effective. This competing interwoven nitinol stent may provide superior stent integrity and fracture-resistance as well as serve areas under extreme mechanical stress. Clinical Impact: Endovascular recanalization is a widely accepted and recommended treatment for symptomatic peripheral artery diseases. The Innospring® stent is a novel self-expanding interwoven stent containing eight nitinol wires with additional radial force, fracture-resistance, and visibility under fluoroscopy. This first-in-human study using the Innospring® stent in patients with femoropopliteal occlusive disease reported that stenting of the superficial femoral and popliteal arteries using the Innospring® stent is safe and effective. This competing interwoven nitinol stent may provide an impressive stent integrity and fracture-resistance as well as serve areas under extreme mechanical stress. [ABSTRACT FROM AUTHOR]

A novel chiral molecularly imprinted polymer TiO2 nanoparticle was synthesized in one step for the enantioseparation of phenylalanine in coated capillary electrochromatography. To the author's knowledge, the chiral molecularly imprinted nanomaterials have still not been reported, to date. Chiral molecularly imprinted TiO2 nanomaterials (L-PHE@MIP(APTES-TEOS)@TiO2) were used as a chiral stationary phase to separate the phenylalanine enantiomers in coated capillary electrochromatography (CEC). The imprinted coating was prepared from L-phenylalanine (L-PHE) as the template, TiO2 nanoparticles (NPs) as the support substrate, 3-aminopropyltriethoxysilane (APTES) as the functional monomer, and tetraethyl silicate (TEOS) as the cross-linker. Scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) were used for the characterization of the L-PHE@MIP(APTES-TEOS)@TiO2@capillary. Fourier transform infrared spectra (FT-IR), transmission electron microscopy (TEM), and thermogravimetric analysis (TGA) were employed for the characterization of the L-PHE@MIP(APTES-TEOS)@TiO2. The effects of the applied voltage, pH value, buffer concentration, and acetonitrile content were investigated experimentally to determine the optimum conditions for CEC. The best resolution for phenylalanine enantiomers by CEC reached a value of 3.48. In addition, the specific recognition effect of L-PHE@MIP(APTES-TEOS)@TiO2 on PHE enantiomers was studied by selective experiment. Finally, adsorption kinetic research, adsorption equilibrium isotherm study, and adsorption thermodynamic experiment were carried out to investigate the separation mechanism of PHE enantiomers with the L-PHE@MIP (APTES-TEOS)@TiO2@capillary, and the results were consistent with those of CEC experiments. [ABSTRACT FROM AUTHOR]